China, India Drug Markets So Big GSK, Others Face Staff-Poaching
This article was originally published in PharmAsia News
Executive Summary
China and India have become such attractive sources of potential sales for multinational drug makers such as U.K.-based GlaxoSmithKline, the companies face a highly competitive market for sales representatives